{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:32:06Z","timestamp":1791595926262,"version":"4.3.4"},"reference-count":138,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibodies"],"abstract":"<jats:p>Intravenous immune globulin (IVIG) is made after processing plasma from healthy donors. It is composed mainly of pooled immunoglobulin and has clinical evidence-based applications in adult and pediatric populations. Recently, several clinical applications have been proposed for managing conditions in the neonatal population, such as hemolytic disease of the newborn, treatment, and prophylaxis for sepsis in high-risk neonates, enterovirus parvovirus and COVID-19 related neonatal infections, fetal and neonatal immune-induced thrombocytopenia, neonatal hemochromatosis, neonatal Kawasaki disease, and some types of immunodeficiency. The dosing, mechanism of action, effectiveness, side effects, and adverse reactions of IVIG have been relatively well studied in adults but are not well described in the neonatal population. This review aims to provide the most recent evidence and consensus guidelines about the use of IVIG in the fetus and neonate.<\/jats:p>","DOI":"10.3390\/antib9040060","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T10:29:00Z","timestamp":1604485740000},"page":"60","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Intravenous Immune Globulin Uses in the Fetus and Neonate: A Review"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2285-2963","authenticated-orcid":false,"given":"Mahdi","family":"Alsaleem","sequence":"first","affiliation":[{"name":"Pediatrics Department, Neonatology, Children\u2019s Mercy Hospital, Kansas City, MO 64108, USA"},{"name":"Pediatrics Department, University of Kansas, Wichita, KS 67208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12016-015-8499-2","article-title":"Impact of immunoglobulin therapy in pediatric disease: A review of immune mechanisms","volume":"51","author":"Wong","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Barahona Afonso, A.F., and Jo\u00e3o, C.M.P. (2016). The production processes and biological effects of intravenous immunoglobulin. Biomolecules, 6.","DOI":"10.3390\/biom6010015"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.transci.2016.12.017","article-title":"Mechanisms of action of intravenous immunoglobulin","volume":"56","author":"Chaigne","year":"2017","journal-title":"Transfus. Apher. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.bi.59.070190.002255","article-title":"Antibody-antigen complexes","volume":"59","author":"Davies","year":"1990","journal-title":"Annu. Rev. Biochem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/19420862.2016.1190060","article-title":"Structural diversity in a human antibody germline library","volume":"8","author":"Teplyakov","year":"2016","journal-title":"MAbs Taylor Fr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.4049\/jimmunol.1701271","article-title":"Passive serum therapy to immunomodulation by IVIG: A fascinating journey of antibodies","volume":"200","author":"Negi","year":"2018","journal-title":"J. Immunol."},{"key":"ref_7","first-page":"e6","article-title":"Intravenous Immunoglobulin and Its Clinical Applications","volume":"46","year":"2017","journal-title":"Pediatr. Ann."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.mjafi.2013.05.011","article-title":"Intravenous immunoglobulin in pediatrics: A review","volume":"70","author":"Prasad","year":"2014","journal-title":"Med. J. Armed Forces India"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e370","DOI":"10.1542\/neo.11-7-e370","article-title":"Intravenous immune globulin: Clinical applications in the newborn","volume":"11","author":"Navarro","year":"2010","journal-title":"NeoReviews"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cct.2019.02.008","article-title":"The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease","volume":"79","author":"Roberts","year":"2019","journal-title":"Contemp. Clin. Trials"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MPG.0000000000002256","article-title":"A phase I\/IIa trial of intravenous immunoglobulin following portoenterostomy in biliary atresia","volume":"68","author":"Mack","year":"2019","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2302\/kjm.40.35","article-title":"A centennial review; the 1890 tetanus antitoxin paper of von Behring and Kitasato and the related developments","volume":"40","author":"Kantha","year":"1991","journal-title":"Keio J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1084\/jem.9.2.142","article-title":"Experimental cerebro-spinal meningitis in monkeys","volume":"9","author":"Flexner","year":"1907","journal-title":"J. Exp. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1084\/jem.9.2.168","article-title":"Concerning a serum-therapy for experimental infection with diplococcus intracellularis","volume":"9","author":"Flexner","year":"1907","journal-title":"J. Exp. Med."},{"key":"ref_15","first-page":"475","article-title":"Use of placental extract in prevention and modification of measles","volume":"45","author":"McKhann","year":"1933","journal-title":"Am. J. Dis. Child."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.9.6.722","article-title":"Agammaglobulinemia","volume":"9","author":"Bruton","year":"1952","journal-title":"Pediatrics"},{"key":"ref_17","unstructured":"HYPOGAMMAGLOBULINAEMIA MWPO (1971). Hypogammaglobulinaemia in the United Kingdom, Her Majesty\u2019s Stationery Office."},{"key":"ref_18","first-page":"193","article-title":"Treatment of defects of humoral immunity","volume":"19","author":"Eibl","year":"1983","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"ref_19","unstructured":"Finlayson, J., and Alving, B. (1979). Overview of potential uses for imunoglobulin preparations, possible etiologies of adverse reactions, and ideal characteristics of intravenous preparations. Immunoglobulins: Characteristics and Uses of Intravenous Preparations Department of Health and Human Services, Bethesda."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1651-2227.1991.tb11828.x","article-title":"High-dose intravenous gammaglobulin therapy for neonatal immune haemolytic jaundice due to blood group incompatibility","volume":"80","author":"Sato","year":"1991","journal-title":"Acta Paediatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.iac.2008.06.004","article-title":"History of immunoglobulin replacement","volume":"28","author":"Eibl","year":"2008","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2016.09.023","article-title":"Update on the use of immunoglobulin in human disease: A review of evidence","volume":"139","author":"Perez","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/trf.14427","article-title":"Clinical indications for intravenous immunoglobulin utilization in a tertiary medical center: A 9-year retrospective study","volume":"58","author":"Shemer","year":"2018","journal-title":"Transfusion"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"105868","DOI":"10.1016\/j.intimp.2019.105868","article-title":"Changing trends in IVIG use in pediatric patients: A retrospective review of practices in a network of major USA pediatric hospitals","volume":"76","author":"Balch","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.transci.2018.01.008","article-title":"Impact of organizational interventions on reducing inappropriate intravenous immunoglobulin (IVIG) usage: A systematic review and meta-analysis","volume":"57","author":"Diep","year":"2018","journal-title":"Transfus. Apher. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/ced.13552","article-title":"Intravenous immunoglobulins in dermatology. Part 2: Clinical indications and outcomes","volume":"43","author":"Forbat","year":"2018","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_27","first-page":"37","article-title":"The prevalence of the ABO hemolytic disease of the newborn and its complications in an Iranian population","volume":"8","author":"Firouzi","year":"2018","journal-title":"Iran. J. Pediatr. Hematol. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5958\/0974-360X.2020.00028.1","article-title":"Prevalence of ABO Incompatibility and its effect on Neonates Hyperbilirubinemia","volume":"13","author":"Abbas","year":"2020","journal-title":"Res. J. Pharm. Technol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/MPH.0000000000001248","article-title":"Severe ABO Hemolytic Disease of the Newborn Requiring Exchange Transfusion","volume":"41","author":"Metcalf","year":"2019","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Watchko, J.F. (2018). Neonatal indirect hyperbilirubinemia and kernicterus. Avery\u2019s Diseases of the Newborn, Elsevier.","DOI":"10.1016\/B978-0-323-40139-5.00084-X"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Alcock, G.S., and Liley, H. (2002). Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD003313"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"F6","DOI":"10.1136\/fn.88.1.F6","article-title":"Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn","volume":"88","author":"Gottstein","year":"2003","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Arneth, B. (2020). Neonatal Immune Incompatibilities between Newborn and Mother. J. Clin. Med., 9.","DOI":"10.3390\/jcm9051470"},{"key":"ref_34","unstructured":"Ramasethu, J., and Luban, N.L. (2006). Alloimmune hemolytic disease of the newborn. Williams Hematology, McGraw-Hill. [7th ed.]."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1542\/neo.14-2-e83","article-title":"Hemolytic disease of the fetus and newborn","volume":"14","author":"Ross","year":"2013","journal-title":"NeoReviews"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Lyons, P., and McLaughlin, N. (2020). Rh Isoimmunization. Obstetrics in Family Medicine: A Practical Guide, Springer.","DOI":"10.1007\/978-3-030-39888-0"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-0037-1606609","article-title":"Prevention of RhD alloimmunization: A comparison of four national guidelines","volume":"35","author":"Sperling","year":"2018","journal-title":"Am. J. Perinatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1179\/2046905512Y.0000000002","article-title":"Morbidity of ABO haemolytic disease in the newborn","volume":"32","author":"Bhat","year":"2012","journal-title":"Paediatr. Int. Child Health"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s12098-018-2663-7","article-title":"Anemia Due to ABO Incompatibility in a Neonate","volume":"85","author":"Atsumi","year":"2018","journal-title":"Indian J. Pediatr."},{"key":"ref_40","unstructured":"Hall, V., and darshini Avulakunta, I. (2020). Hemolytic Diseases of the Newborn, StatPearls Publishing."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tmrv.2016.05.008","article-title":"Hemolytic disease of the fetus and newborn: Modern practice and future investigations","volume":"30","author":"Hendrickson","year":"2016","journal-title":"Transfus. Med. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/17474086.2017.1305265","article-title":"Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn\u2013review on current management and outcome","volume":"10","author":"Zwiers","year":"2017","journal-title":"Expert Rev. Hematol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e190858","DOI":"10.1001\/jamanetworkopen.2019.0858","article-title":"Rates of extreme neonatal hyperbilirubinemia and kernicterus in children and adherence to national guidelines for screening, diagnosis, and treatment in Sweden","volume":"2","author":"Gustafson","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1038\/jp.2008.213","article-title":"A proposal to prevent severe neonatal hyperbilirubinemia and kernicterus","volume":"29","author":"Bhutani","year":"2009","journal-title":"J. Perinatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/sj.jp.7211152","article-title":"Kernicterus: Epidemiological strategies for its prevention through systems-based approaches","volume":"24","author":"Bhutani","year":"2004","journal-title":"J. Perinatol."},{"key":"ref_46","first-page":"199","article-title":"The neurological sequelae of neonatal hyperbilirubinemia: Definitions, diagnosis and treatment of the kernicterus spectrum disorders (KSDs)","volume":"13","author":"Pichon","year":"2017","journal-title":"Curr. Pediatr. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000113463","article-title":"Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants\u2265 35 weeks gestation","volume":"94","author":"Bhutani","year":"2008","journal-title":"Neonatology"},{"key":"ref_48","first-page":"558","article-title":"Hyperbilirubinemia in neonates: Types, causes, clinical examinations, preventive measures and treatments: A narrative review article","volume":"45","author":"Ullah","year":"2016","journal-title":"Iran. J. Public Health"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2010.10.030","article-title":"The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders","volume":"127","author":"Ballow","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1515\/jpme.1993.21.3.183","article-title":"Intravenous immunoglobulin therapy in neonatal immune hemolytic jaundice","volume":"21","author":"Ergaz","year":"1993","journal-title":"J. Perinat. Med. Off. J. WAPM"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1515\/jpme.1995.23.6.443","article-title":"Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease","volume":"23","author":"Voto","year":"1995","journal-title":"J. Perinat. Med. Off. J. WAPM"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/tropej\/47.1.50","article-title":"Brief report. Multiple dose IVIG treatment in neonatal immune hemolytic jaundice","volume":"47","author":"Tanyer","year":"2001","journal-title":"J. Trop. Pediatr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1203\/00006450-199708000-00003","article-title":"Methylprednisolone attenuates the pulmonary hypertensive response in porcine meconium aspiration","volume":"42","author":"Soukka","year":"1997","journal-title":"Pediatr. Res."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Hyperbilirubinemia AAoPSo (2004). Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics, 114, 297.","DOI":"10.1542\/peds.114.1.297"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Zwiers, C., Scheffer-Rath, M.E.A., Lopriore, E., de Haas, M., and Liley, H.G. (2018). Immunoglobulin for alloimmune hemolytic disease in neonates. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD003313.pub2"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"957","DOI":"10.21608\/ejhm.2019.25779","article-title":"Effect of Intravenous Immunoglobulin in Reducing Bilirubin Levels in Hemolytic Disease of Newborn","volume":"74","author":"Ahmed","year":"2019","journal-title":"Egypt. J. Hosp. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"760","DOI":"10.14740\/jocmr4003","article-title":"Intravenous Immunoglobulins as Adjunct Treatment to Phototherapy in Isoimmune Hemolytic Disease of the Newborn: A Retrospective Case-Control Study","volume":"11","author":"Badran","year":"2019","journal-title":"J. Clin. Med. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"F325","DOI":"10.1136\/archdischild-2013-304878","article-title":"Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: An updated systematic review and meta-analysis","volume":"99","author":"Louis","year":"2014","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"Thurik","year":"2015","journal-title":"Vox Sang."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1751-2824.2008.00189.x","article-title":"Haemolytic diseases","volume":"3","author":"Armstrong","year":"2008","journal-title":"ISBT Sci. Ser."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1542\/peds.2010-3242","article-title":"Intravenous immunoglobulin in neonates with rhesus hemolytic disease: A randomized controlled trial","volume":"127","author":"Walther","year":"2011","journal-title":"Pediatrics"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Zdravic, D., Yougbare, I., Vadasz, B., Li, C., Marshall, A.H., Chen, P., Kjeldsen-Kragh, J., and Ni, H. (2016). Fetal and neonatal alloimmune thrombocytopenia. Seminars in Fetal and Neonatal Medicine, Elsevier.","DOI":"10.1016\/j.siny.2015.12.004"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00005-015-0371-9","article-title":"Fetal\/neonatal alloimmune thrombocytopenia: Pathogenesis, diagnostics and prevention","volume":"64","author":"Brojer","year":"2016","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/vox.12725","article-title":"Maternal HPA-1a antibody level and its role in predicting the severity of Fetal\/Neonatal Alloimmune Thrombocytopenia: A systematic review","volume":"114","author":"Bertrand","year":"2019","journal-title":"Vox Sang."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bpobgyn.2019.01.017","article-title":"Foetal and neonatal alloimmune thrombocytopenia","volume":"58","author":"Winkelhorst","year":"2019","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2016-10-739656","article-title":"Antenatal management in fetal and neonatal alloimmune thrombocytopenia: A systematic review","volume":"129","author":"Winkelhorst","year":"2017","journal-title":"Blood"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJM199707033370104","article-title":"Fetal Alloimmune Thrombocytopenia","volume":"337","author":"Bussel","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/AOG.0b013e31823403f4","article-title":"Fetal and neonatal alloimmune thrombocytopenia: A management algorithm based on risk stratification","volume":"118","author":"Pacheco","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"ref_69","first-page":"1783","article-title":"Effects of antepartum therapy for fetal alloimmune thrombocytopenia on maternal lifestyle","volume":"29","author":"Rossi","year":"2016","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_70","first-page":"1329","article-title":"Postnatal intervention for the treatment of FNAIT: A systematic review","volume":"39","author":"Baker","year":"2019","journal-title":"J. Perinatol. Off. J. Calif. Perinat. Assoc."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/bjh.15216","article-title":"Treatment and outcomes of fetal\/neonatal alloimmune thrombocytopenia: A nationwide cohort study in newly detected cases","volume":"184","author":"Winkelhorst","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/vox.12036","article-title":"Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura","volume":"105","author":"Walther","year":"2013","journal-title":"Vox Sang."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"F359","DOI":"10.1136\/fn.88.5.F359","article-title":"Neonatal thrombocytopenia: Causes and management","volume":"88","author":"Roberts","year":"2003","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Ohlsson, A., and Lacy, J.B. (2015). Intravenous immunoglobulin for suspected or proven infection in neonates. Cochrane Database Syst. Rev., CD001239.","DOI":"10.1002\/14651858.CD001239.pub5"},{"key":"ref_75","first-page":"CD000361","article-title":"Intravenous immunoglobulin for preventing infection in preterm and\/or low birth weight infants","volume":"1","author":"Ohlsson","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/clinids\/20.5.1201","article-title":"Neonatal enterovirus infection: Virology, serology, and effects of intravenous immune globulin","volume":"20","author":"Abzug","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"ref_77","first-page":"668","article-title":"Intrauterine anemia due to parvovirus B19: Successful treatment with intravenous immunoglobulins","volume":"84","author":"Rugolotto","year":"1999","journal-title":"Haematologica"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s12098-007-0099-6","article-title":"Parvovirus B19 nonimmune hydrops in a neonate","volume":"74","author":"Manchanda","year":"2007","journal-title":"Indian J. Pediatr."},{"key":"ref_79","first-page":"E005","article-title":"Frist case of severe childhood novel coronavirus pneumonia in China","volume":"58","author":"Chen","year":"2020","journal-title":"Zhonghua er ke za zhi Chin. J. Pediatr."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000477616","article-title":"Antenatal Treatment with Intravenous Immunoglobulin to Prevent Gestational Alloimmune Liver Disease: Comparative Effectiveness of 14-Week versus 18-Week Initiation","volume":"43","author":"Whitington","year":"2018","journal-title":"Fetal Diagn. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jpeds.2009.04.012","article-title":"treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin","volume":"155","author":"Rand","year":"2009","journal-title":"J. Pediatr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(99)70246-5","article-title":"Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: A retrospective survey of 31 patients","volume":"134","author":"Quartier","year":"1999","journal-title":"J. Pediatr."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"ref_84","first-page":"2693","article-title":"Score-based immunoglobulin G therapy of patients with sepsis: The SBITS study","volume":"35","author":"Werdan","year":"2007","journal-title":"Crit. Care Med."},{"key":"ref_85","first-page":"Cd001090","article-title":"Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock","volume":"2013","author":"Alejandria","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/MCC.0000000000000639","article-title":"Intravenous immunoglobulin for adjunctive treatment of severe infections in ICUs","volume":"25","author":"Aubron","year":"2019","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1823.e4","DOI":"10.1016\/j.clinthera.2019.06.010","article-title":"Evaluation of the Effect of Intravenous Immunoglobulin Dosing on Mortality in Patients with Sepsis: A Network Meta-analysis","volume":"41","author":"Yang","year":"2019","journal-title":"Clin. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3476(96)70191-9","article-title":"Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network","volume":"129","author":"Stoll","year":"1996","journal-title":"J. Pediatr."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Ohlsson, A., and Lacy, J.B. (2004). Intravenous immunoglobulin for preventing infection in preterm and\/or low-birth-weight infants. Cochrane Database Syst. Rev., CD000361.","DOI":"10.1002\/14651858.CD000361.pub2"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0095-5108(18)30672-9","article-title":"Neonatal sepsis: The potential for immunotherapy","volume":"15","author":"Baley","year":"1988","journal-title":"Clin Perinatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MOP.0b013e32832925e5","article-title":"Immunotherapy in neonatal sepsis: Advances in treatment and prophylaxis","volume":"21","author":"Benjamin","year":"2009","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa1100441","article-title":"Treatment of neonatal sepsis with intravenous immune globulin","volume":"365","author":"Brocklehurst","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1824-7288-39-63","article-title":"Are IgM-enriched immunoglobulins an effective adjuvant in septic VLBW infants?","volume":"39","author":"Capasso","year":"2013","journal-title":"Ital. J. Pediatr."},{"key":"ref_94","first-page":"1","article-title":"Prolonged intravenous immunoglobulin treatment in very low birth weight infants with late onset sepsis","volume":"13","year":"2019","journal-title":"J. Neonatal-Perinat. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/jp.2009.197","article-title":"Does IVIg administration yield improved immune function in very premature neonates?","volume":"30","author":"Wynn","year":"2010","journal-title":"J. Perinatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fped.2019.00469","article-title":"Echovirus type 7 virus-associated hemophagocytic syndrome in a neonate successfully treated with intravenous immunoglobulin therapy: A case report","volume":"7","author":"Watanabe","year":"2019","journal-title":"Front. Pediatr."},{"key":"ref_97","first-page":"254","article-title":"Intravenous immunoglobulin in disseminated neonatal echovirus 11 infection","volume":"8","author":"Johnston","year":"1989","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcv.2015.01.013","article-title":"Effect of intravenous immunoglobulin for neonates with severe enteroviral infections with emphasis on the timing of administration","volume":"64","author":"Yen","year":"2015","journal-title":"J. Clin. Virol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMp2004361","article-title":"History in a Crisis\u2014Lessons for Covid-19","volume":"382","author":"Jones","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMe2002387","article-title":"Covid-19\u2014Navigating the Uncharted","volume":"382","author":"Fauci","year":"2020","journal-title":"N. Engl. J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMoa2005412","article-title":"Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington","volume":"382","author":"McMichael","year":"2020","journal-title":"N. Engl. J."},{"key":"ref_102","first-page":"m2094","article-title":"Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: Prospective observational study","volume":"369","author":"Toubiana","year":"2020","journal-title":"BMJ (Clin. Res.)"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(20)31129-6","article-title":"Kawasaki-like disease: Emerging complication during the COVID-19 pandemic","volume":"395","author":"Viner","year":"2020","journal-title":"Lancet"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jamapediatrics.2020.0878","article-title":"Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China","volume":"174","author":"Zeng","year":"2020","journal-title":"JAMA Pediatr."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Sakoulas, G., Geriak, M., Kullar, R., Greenwood, K., Habib, M., Vyas, A., Ghafourian, M., Dintyala, V.N.K., and Haddad, F. (2020). Intravenous Immunoglobulin (IVIG) Significantly Reduces Respiratory Morbidity in COVID-19 Pneumonia: A Prospective Randomized Trial. A Prospect. Randomized Trial.","DOI":"10.1101\/2020.07.20.20157891"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"106560","DOI":"10.1016\/j.intimp.2020.106560","article-title":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids","volume":"84","author":"Saghazadeh","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jinf.2020.03.044","article-title":"Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19","volume":"81","author":"Xie","year":"2020","journal-title":"J. Infect."},{"key":"ref_108","first-page":"1","article-title":"Novel Coronavirus disease (COVID-19) in newborns and infants: What we know so far","volume":"46","author":"Piersigilli","year":"2020","journal-title":"Ital. J. Pediatr."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"51","DOI":"10.21037\/tp.2020.02.06","article-title":"Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia","volume":"9","author":"Zhu","year":"2020","journal-title":"Transl. Pediatr."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fped.2020.00287","article-title":"Coronavirus Disease 2019 (COVID-19) in Neonates and Children From China: A Review","volume":"8","author":"Yu","year":"2020","journal-title":"Front. Pediatr."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21678707.2020.1709441","article-title":"Congenital cytomegalovirus infection: Epidemiology, prediction, diagnosis, and emerging treatment options for symptomatic infants","volume":"8","author":"Nagano","year":"2020","journal-title":"Expert Opin. Orphan Drugs"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","article-title":"A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus","volume":"370","author":"Revello","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_113","first-page":"E25","article-title":"Prophylactic intravenous immunoglobulin injections to mothers with primary cytomegalovirus infection","volume":"60","author":"Tanimura","year":"2014","journal-title":"Kobe J. Med. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1891\/0730-0832.37.5.271","article-title":"Gestational Alloimmune Liver Disease: A Case Study","volume":"37","author":"Kasko","year":"2018","journal-title":"Neonatal Netw."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"123.e1","DOI":"10.1016\/j.jpeds.2017.12.054","article-title":"The Effects of Gestational Alloimmune Liver Disease on Fetal and Infant Morbidity and Mortality","volume":"196","author":"Taylor","year":"2018","journal-title":"J. Pediatr."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jpeds.2011.03.048","article-title":"Gestational alloimmune liver disease in cases of fetal death","volume":"159","author":"Whitington","year":"2011","journal-title":"J. Pediatr."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/14767058.2018.1487940","article-title":"The Japanese experience and pharmacokinetics of antenatal maternal high-dose immunoglobulin treatment as a prophylaxis for neonatal hemochromatosis in siblings","volume":"33","author":"Okada","year":"2020","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1055\/s-0038-1649339","article-title":"Liver Failure and Conjugated Hyperbilirubinemia in a Preterm Neonate: Role of Early IVIG and Exchange Transfusion","volume":"8","author":"Nair","year":"2018","journal-title":"AJP Rep."},{"key":"ref_119","first-page":"7432859","article-title":"Neonatal Liver Failure and Congenital Cirrhosis due to Gestational Alloimmune Liver Disease: A Case Report and Literature Review","volume":"2017","author":"Kieling","year":"2017","journal-title":"Case Rep. Pediatr."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"985646","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies","volume":"2012","author":"Palmeira","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin. Immunol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00431-017-2937-5","article-title":"Dissecting Kawasaki disease: A state-of-the-art review","volume":"176","author":"Dietz","year":"2017","journal-title":"Eur. J. Pediatr."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"F135","DOI":"10.1136\/fn.86.2.F135","article-title":"Classical Kawasaki disease in a neonate","volume":"86","author":"Stanley","year":"2002","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1651-2227.1996.tb14201.x","article-title":"Epidemiology of infant Kawasaki disease with a report of the youngest neonatal case ever reported in Japan","volume":"85","author":"Tsuchida","year":"1996","journal-title":"Acta Paediatr."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0022-3476(86)80689-8","article-title":"Clinical spectrum of Kawasaki disease in infants younger than 6 months of age","volume":"109","author":"Burns","year":"1986","journal-title":"J. Pediatr."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.27308","article-title":"evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial","volume":"62","author":"Friedman","year":"2010","journal-title":"Arthr. Rheum."},{"key":"ref_127","first-page":"706","article-title":"Plasmapheresis, intravenous immunoglobulins and bethametasone-a combined protocol to treat autoimmune congenital heart block: A prospective cohort study","volume":"34","author":"Ruffatti","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_128","first-page":"126","article-title":"A randomized, double-blind, placebo-controlled investigation of the safety of intravenous immune globulin administration to preterm neonates","volume":"9","author":"Christensen","year":"1989","journal-title":"J. Perinatol. Off. J. Calif. Perinat. Assoc."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1651-2227.2009.01279.x","article-title":"Necrotizing enterocolitis following the use of intravenous immunoglobulin for haemolytic disease of the newborn","volume":"98","author":"Navarro","year":"2009","journal-title":"Acta Paediatr."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1440-1754.1993.tb00442.x","article-title":"A fatal case of necrotizing enterocolitis in a neonate with polyagglutination of red blood cells","volume":"29","author":"Marshall","year":"1993","journal-title":"J. Paediatr. Child Health"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1111\/trf.13721","article-title":"Use of intravenous immunoglobulin in neonates at a tertiary academic hospital: A retrospective 11-year study","volume":"56","author":"Lieberman","year":"2016","journal-title":"Transfusion"},{"key":"ref_132","first-page":"3902","article-title":"The effect of immunoglobulin treatment for hemolysis on the incidence of necrotizing enterocolitis\u2014A meta-analysis","volume":"20","author":"Yang","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s12098-014-1678-y","article-title":"A Doppler velocimetry evaluation of intestinal blood flow characteristics in neonates receiving intravenous immunoglobulin therapy: A prospective observational study","volume":"82","author":"Louis","year":"2015","journal-title":"Indian J. Pediatr."},{"key":"ref_134","first-page":"2641","article-title":"Efficacy of subcutaneous immunoglobulins in primary immunodeficiency with Crohn\u2019s-like phenotype: Report of a case","volume":"19","author":"Sanges","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000073059","article-title":"Therapy with intravenous immunoglobulins: Complications and side-effects","volume":"50","author":"Wittstock","year":"2003","journal-title":"Eur. Neurol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/jcn.JCN_44_19","article-title":"Neonatal thrombosis after antenatal treatment of neonatal alloimmune thrombocytopenia with intravenous immunoglobulin","volume":"8","author":"Hinson","year":"2019","journal-title":"J. Clin. Neonatol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/ccr3.329","article-title":"Cardiac rhythm abnormalities during intravenous immunoglobulin G (IVIG) infusion in two newborn infants: Coincidence or association?","volume":"3","author":"Tufekci","year":"2015","journal-title":"Clin. Case Rep."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s12098-014-1509-1","article-title":"Apnea as a complication of intravenous immunoglobulin therapy in a neonate","volume":"81","author":"Kumar","year":"2014","journal-title":"Indian J. Pediatr."}],"container-title":["Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4468\/9\/4\/60\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:29:16Z","timestamp":1760178556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4468\/9\/4\/60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":138,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["antib9040060"],"URL":"https:\/\/doi.org\/10.3390\/antib9040060","relation":{},"ISSN":["2073-4468"],"issn-type":[{"value":"2073-4468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]}}}